EVIA Life Sciences Inc. funding
EVIA Life Sciences Inc., a biotechnology company based in Tokyo, Japan, filed a Form D with the SEC on November 2, 2026 and reported $700K raised of a $5.5M offering.
Amount raised$700K
Offering size$5.5M
Filed with the SECNovember 2, 2026
First saleOctober 23, 2026
IndustryBiotechnology
SecuritiesEquity
LocationTokyo, Japan
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 2
Other health care rounds
Zai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyKaigene, Inc.$55M · Oct 14BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyVesalius Longevity Labs Inc.$30.1M · Nov 3Pharmaceuticals